HERPES-SIMPLEX VIRUS AND ATHEROSCLEROSIS

被引:0
作者
VISSER, MR
VERCELLOTTI, GM
机构
[1] UNIV HOSP UTRECHT,INFECT DIS LAB,UTRECHT,NETHERLANDS
[2] UNIV MINNESOTA,SCH MED,DEPT MED,DIV HEMATOL,MINNEAPOLIS,MN 55455
关键词
HERPES SIMPLEX VIRUS; ATHEROSCLEROSIS; ENDOTHELIUM; LEUKOCYTES; HEMOSTASIS; COAGULATION; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTIN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:39 / 42
页数:4
相关论文
共 49 条
[21]   UNLIKELY ASSOCIATION BETWEEN CLINICALLY APPARENT HERPESVIRUS-INFECTION AND CORONARY INCIDENCE AT OLDER AGES - THE FRAMINGHAM HEART-STUDY [J].
HAVLIK, RJ ;
BLACKWELDER, WC ;
KASLOW, R ;
CASTELLI, W .
ARTERIOSCLEROSIS, 1989, 9 (06) :877-880
[22]   POTENTIATED ADHERENCE OF SICKLE ERYTHROCYTES TO ENDOTHELIUM INFECTED BY VIRUS [J].
HEBBEL, RP ;
VISSER, MR ;
GOODMAN, JL ;
JACOB, HS ;
VERCELLOTTI, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (05) :1503-1506
[23]   INHIBITION OF PROTEOGLYCAN SYNTHESIS IN HUMAN ENDOTHELIAL-CELLS AFTER INFECTION WITH HERPES-SIMPLEX VIRUS TYPE-1 INVITRO [J].
KANER, RJ ;
IOZZO, RV ;
ZIAIE, Z ;
KEFALIDES, NA .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 2 (05) :423-431
[24]   FIBROBLAST GROWTH-FACTOR RECEPTOR IS A PORTAL OF CELLULAR ENTRY FOR HERPES-SIMPLEX VIRUS TYPE-1 [J].
KANER, RJ ;
BAIRD, A ;
MANSUKHANI, A ;
BASILICO, C ;
SUMMERS, BD ;
FLORKIEWICZ, RZ ;
HAJJAR, DP .
SCIENCE, 1990, 248 (4961) :1410-1413
[25]  
KEFALIDES NA, 1986, LAB INVEST, V55, P328
[26]   INFECTION OF VASCULAR ENDOTHELIAL-CELLS WITH HERPES-SIMPLEX VIRUS ENHANCES TISSUE FACTOR ACTIVITY AND REDUCES THROMBOMODULIN EXPRESSION [J].
KEY, NS ;
VERCELLOTTI, GM ;
WINKELMANN, JC ;
MOLDOW, CF ;
GOODMAN, JL ;
ESMON, NL ;
ESMON, CT ;
JACOB, HS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7095-7099
[27]  
KUBOTA Y, 1987, J IMMUNOL, V138, P1137
[28]   REACTIVITY AGAINST HERPES-SIMPLEX VIRUS IN PATIENTS WITH HEAD AND NECK-CANCER [J].
LARSSON, PA ;
EDSTROM, S ;
WESTIN, T ;
NORDKVIST, A ;
HIRSCH, JM ;
VAHLNE, A .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (01) :14-18
[29]  
MACARAK EJ, 1985, LAB INVEST, V53, P280
[30]  
MELNICK JL, 1983, LANCET, V2, P644